ScinoPharm Taiwan, Ltd. (TPE:1789)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Others	15.89M	19.95M	53.48M	42.62M	25.99M
Others Growth	-20.37%	-62.69%	25.47%	64.00%	50.52%
Inter Segment	-351.04M	-431.89M	-519.61M	-342.84M	-388.66M
Changshu Shenlong	389.67M	679.16M	645.26M	494.83M	482.18M
Changshu Shenlong Growth	-42.62%	5.25%	30.40%	2.62%	9.42%
Scinopharm Taiwan, Ltd.	3.11B	3.14B	3.01B	3.07B	2.64B
Scinopharm Taiwan, Ltd. Growth	-0.96%	4.39%	-2.04%	16.14%	-13.24%
Total	3.16B	3.41B	3.19B	3.26B	2.76B
Total Growth	-7.13%	6.91%	-2.39%	18.16%	-10.40%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Asia	950.46M	1.42B	1.17B	1.09B	999.19M
Asia Growth	-32.84%	20.62%	7.81%	8.93%	31.20%
Europe	479.49M	675.06M	690.17M	582.66M	583.05M
Europe Growth	-28.97%	-2.19%	18.45%	-0.07%	-51.11%
India	438.40M	529.29M	525.27M	577.19M	227.80M
India Growth	-17.17%	0.77%	-9.00%	153.38%	-36.44%
United States	855.95M	403.66M	490.58M	635.74M	766.06M
United States Growth	112.04%	-17.72%	-22.83%	-17.01%	32.30%
Taiwan	400.93M	346.88M	271.50M	261.87M	110.04M
Taiwan Growth	15.58%	27.76%	3.68%	137.98%	-14.71%
Other	38.20M	36.07M	35.20M	118.18M	76.19M
Other Growth	5.90%	2.47%	-70.21%	55.11%	22.35%
Total	3.16B	3.41B	3.19B	3.26B	2.76B
Total Growth	-7.13%	6.91%	-2.39%	18.16%	-10.40%

Source: S&P Global Market Intelligence.